"I spend a lot of time outdoors on the beach and at the pool. I wanted to create a special table to help prevent my phone from overheating in the sun," said an inventor, from Delray Beach, Fla., "so I ...

Tim Deacon, Executive Vice President & Chief Financial Officer, Sun Life, will participate in a fireside chat at the National Bank Financial Markets' 23rd Annual Financial Services Conference.

Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Get real-time Men's College Basketball coverage and scores as Tulane Green Wave takes on Memphis Tigers. We bring you the latest game previews, live stats, expert picks and recaps on CBSSports.com ...

Sun Pharmaceutical Industries Ltd. closed 14.10% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...

While there's been a glimpse of cases beginning to slow, experts have warned a second wave could be on the ... trial will see a vaccine developed by pharmaceutical firm Moderna and 2,500 ...

Market rally today: Stocks such as Asian Paints, NTPC, Reliance Industries, Tata Steel, Bajaj Finserv, HUL, Sun Pharma, Adani Ports, Axis Bank, TCS, Titan, Bajaj Finance and HCL Technologies were ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of $300.00. The company’s shares closed yesterday at $245.20.

The future of pharma analytics is about getting people to answers – and questions – quicker, so the time they spend using the next wave of BI tools can have a positive impact on the future ...